Open Access

Lower for longer: reframing the clinical goal for LDL-C. The lower the better is no longer enough

Event: ESC Congress 2022
Topic: Lipid-Lowering Agents
Session type: Satellite Symposium
Sponsored by Novartis Pharma AG
Date: 28 August 2022
Time: 12:45 - 13:45

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

5 presentations in this session

Welcome and introduction: LDL-C: the lower the better is no longer enough.

Speaker: Professor E. Stroes (Amsterdam, NL)
Thumbnail

The perspective of people living with ASCVD: what are the real-world challenges patients face to keep LDL-C lower for longer?

Speaker: Mr N. Johnson (Galway, IE)
Thumbnail

The physician`s perspective: what prevents us from keeping LDL-C lower for longer? Who are the patients that need more help?

Speaker: Professor I. Hilgendorf (Freiburg, DE)
Thumbnail

How do we achieve lower for longer LDL-C levels in patients who can't wait?

Speaker: Professor J. Gonzalez Juanatey (Santiago de Compostela, ES)
Thumbnail

Q&A. Summary, key takeaways and call to action.

Speaker: Professor E. Stroes (Amsterdam, NL)
Thumbnail

5 speakers from this session

Professor Erik Stroes

Academic Medical Centre, Amsterdam (Netherlands (The))
24 presentations
0 follower

Mr Neil Johnson

, Galway (Ireland)
2 presentations
0 follower

Professor Ingo Hilgendorf

University of Freiburg, Freiburg (Germany)
2 presentations
0 follower

Professor Jose Ramon Gonzalez Juanatey

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)
17 presentations
1 follower

Professor Erik Stroes

Academic Medical Centre, Amsterdam (Netherlands (The))
24 presentations
0 follower

This platform is supported by

logo Novo Nordisk